BeeWell

Trials & centers

Ask your doctor

Pick a condition
Breast cancerLung cancerColorectal cancerProstate cancerPancreatic cancerOvarian cancerLeukemiaLymphomaBrain tumorMelanomaLiver cancerMultiple myeloma

Recruiting trials

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

Phase 2 Recruiting

  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California, United States
  • Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis, Indiana, United States
  • More sites
Official record

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Phase 1 & 2 Recruiting

  • University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio, United States
Official record

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

Phase 2 Recruiting

  • Clearview Cancer Institute, Huntsville, Alabama, United States
  • Sharp HealthCare - Sharp Memorial Hospital, San Diego, California, United States
  • H. Lee Moffitt Cancer Center, Tampa, Florida, United States
  • More sites
Official record

Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial

Phase 2 Recruiting

  • Northwestern University, Chicago, Illinois, United States
Official record

Screening and Staging of Benign vs Malignant Pelvic Abnormalities

Observational Recruiting

  • Mayo Clinic in Rochester, Rochester, Minnesota, United States
Official record

A Study of a New PET Scanner in People With Cancer

Observational Recruiting

  • Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only ), Montvale, New Jersey, United States
  • More sites
Official record

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Phase 1 Recruiting

  • Exelixis Clinical Site #67, Phoenix, Arizona, United States
  • Exelixis Clinical Site #1, Tucson, Arizona, United States
  • Exelixis Clinical Site #123, Palo Alto, California, United States
  • More sites
Official record

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

Phase 1 & 2 Recruiting

  • Research Site, Fayetteville, Arkansas, United States
  • Research Site, Los Angeles, California, United States
  • Research Site, Towson, Maryland, United States
  • More sites
Official record
ClinicalTrials.gov

NCI-designated centers

Comprehensive & clinical

Alabama

Arizona

California

Colorado

Connecticut

District of Columbia

  • Georgetown Lombardi Comprehensive Cancer Center

    Washington, District of Columbia

    NCI listingPlan a trip

Florida

Georgia

Hawai'i

Illinois

Indiana

  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center

    Indianapolis, Indiana

    NCI listingPlan a trip

Iowa

Kansas

Kentucky

Maryland

  • Sidney Kimmel Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

    Baltimore, Maryland

    NCI listingPlan a trip

Massachusetts

Michigan

Minnesota

Missouri

Nebraska

New Hampshire

New Jersey

New Mexico

  • University of New Mexico Cancer Research and Treatment Center

    Albuquerque, New Mexico

    NCI listingPlan a trip

New York

North Carolina

Ohio

Oklahoma

Oregon

Pennsylvania

South Carolina

Tennessee

Texas

Utah

Virginia

Washington

  • Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium

    Seattle, Washington

    NCI listingPlan a trip

Wisconsin

NCI-Designated Cancer Centers, June 10, 2026